fbpx skip to Main Content
Catch and Kill Business Acquisition

Why a Catch and Kill Business Acquisition can be Damaging and What to Do about it

Recently Patrick Soon-Shiong, the billionaire biotech investor, was accused of “catching and killing” the drug Cynviloq to stop its progression to market. Research from Yale School of Management’s Song Ma and Florian Ederer, along with co-author Colleen Cunningham, investigates how catch and kill acquisitions may blunt innovation and ultimately be harmful to patients.

Hone the inner business leader with a deeper understanding of global business. Click to know more about the Yale Global Executive Leadership Program (Yale GELP).

Back To Top